Two groups at Harvard University have announced that they have received approval to start human-cloning research designed to create lines of embryonic stem cells to study and treat diseases. “We are ...
Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million from investors. Church’s biotech company GC Therapeutics launched on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results